Integrated Diagnostics Holdings PLC(IDHC)
USD --+0.00%
Reward56Moderate
Risk18Low
📊75%Data
Strong 18% profit margin · Revenue growing 39% YoY
IDHC
+0.0 · +0.00%
USD · LSE
Integrated Diagnostics Holdings PLC | Healthcare
Deep Value
Market Cap:36.91Bn
ℹ️
Reward Rating
56
Moderate
Bottom 50% (model universe)
75% data coverage
ℹ️
Risk Rating
18
Low
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on IDHC to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: $0.80.

What is Integrated Diagnostics Holdings PLC?

Integrated Diagnostics Holdings plc operates as a consumer healthcare company that provides medical diagnostics services to patients.

IDHC · Verdict

Solid reward · low risk

IDHC scores well on volatility and cash flow with no major weaknesses flagged in the model.

Based on 88% data coverage

IDHC · Verdict

What’s working & what to watch

Strengths 4

  • Volatility95/100

    Top decile vs peers

  • Cash flow85/100

    23% free-cash-flow margin

  • Valuation81/100

    P/E 12.9× · PEG 0.52

  • Balance sheet70/100

    Interest covered 9.4×

No major weaknesses flagged.

Model-based scoring. For information only — not financial advice.

What is Integrated Diagnostics Holdings PLC?

Integrated Diagnostics Holdings plc operates as a consumer healthcare company that provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company is listed on the LSE in UK, operating in the Healthcare sector, with a market capitalisation of 36.91B, and a P/E ratio of 0.2x.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Adequate profitability with some margin variability in recent periods.
⚠️ Risk
Below-average volatility supports a steadier risk profile.
💸 Valuation
Currently trading below intrinsic value estimates, suggesting upside potential.

OpenBook Logo Analysis

Reward: Moderate (56)

The scoring profile indicates moderate reward potential, with valuation and profitability as the leading contributors. Risk indicators are low, suggesting a relatively contained downside profile.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap36.91B
P/E Ratio0.1588
Dividend YieldN/A
52 Week High0.835
52 Week Low0.2812
Last AnnualDecember
IPO DateN/A
IncorporatedUK
Shares Outstanding581M
No. of Employees6,309
IndustryDiagnostics & Research
ExchangeLSE
Beta0.283
CurrencyUSD